-
Japanese women MPs want more seats, the porcelain kind
-
Guinea junta chief Doumbouya elected president: election commission
-
Pistons pound Lakers as James marks 41st birthday with loss
-
Taiwan coastguard says Chinese ships 'withdrawing' after drills
-
France's homeless wrap up to survive at freezing year's end
-
Leftist Mamdani to take over as New York mayor under Trump shadow
-
French duo stripped of Sydney-Hobart race overall win
-
Thailand releases 18 Cambodian soldiers held since July
-
Tiny tech, big AI power: what are 2-nanometre chips?
-
Libyans savour shared heritage at reopened national museum
-
Asia markets mixed in final day of 2025 trading
-
Global 'fragmentation' fuelling world's crises: UN refugee chief
-
Difficult dance: Cambodian tradition under threat
-
Regional temperature records broken across the world in 2025
-
'Sincaraz' set to dominate as 2026 tennis season kicks off
-
Bulgaria readies to adopt the euro, nearly 20 years after joining EU
-
Trump v 'Obamacare': US health costs set to soar for millions in 2026
-
Isiah Whitlock Jr., 'The Wire' actor, dies at 71
-
SoftBank lifts OpenAI stake to 11% with $41bln investment
-
Bangladesh mourns ex-PM Khaleda Zia with state funeral
-
TSMC says started mass production of 'most advanced' 2nm chips
-
Australian cricket great Damien Martyn 'in induced coma'
-
Guinea junta chief Doumboya elected president: election commission
-
Apex Provides Recap of 2025 Regional Exploration Drilling and Priority Follow Up Targets at the Cap Critical Minerals Project
-
Guardian Metal Resources PLC Announces Total Voting Rights
-
Caballero defends Maresca after Palmer substitution sparks jeers
-
Depleted Man Utd 'lack quality', says Amorim
-
'We know what we want': Arteta eyes title after Arsenal thrash Villa
-
Arsenal crush Villa to make statement in title race
-
Senegal top AFCON group ahead of DR Congo as Tanzania make history
-
Maresca in the firing line as Chelsea stumble against Bournemouth
-
Senegal top AFCON group, DR Congo to face Algeria in last 16
-
Norway's Magnus Carlsen wins 20th world chess title
-
Patriots star Diggs facing assault charges: reports
-
Journalist Tatiana Schlossberg, granddaughter of JFK, dies at 35
-
Rio receives Guinness record for biggest New Year's bash
-
Jokic out for four weeks after knee injury: Nuggets
-
World bids farewell to 2025, a year of Trump, truces and turmoil
-
Far-right leader Le Pen to attend Brigitte Bardot's funeral
-
Drones dive into aviation's deepest enigma as MH370 hunt restarts
-
German dog owners sit out New Year's Eve chaos in airport hotels
-
Tanzania hold Tunisia to end 45-year wait for AFCON knockout spot
-
10 countries warn of 'catastrophic' Gaza situation
-
Performers cancel concerts at Kennedy center after Trump renaming
-
Burst tyre and speed contributed to Joshua crash say investigators
-
Students join Iran demonstrations after shopkeepers protest
-
Johnson still a Spurs player despite Palace interest, says Frank
-
UAE to pull forces out of Yemen as 24-hour deadline set
-
Chinese leasing firm CALC orders 30 Airbus A320neo planes
-
Germany bank heist nets about 30mn euros in cash, valuables: police
Who should get paid for nature's sequenced genes?
Much of the vanilla that flavors our ice cream today is artificial, derived from the genetic signature of a plant that hundreds of years ago was known only to an Indigenous Mexican tribe.
The plant's sequenced genomic information, available on public databases, was used as the basis for a synthetic flavoring that today competes with vanilla grown in several countries, mainly by small-scale farmers.
Few, if any, benefits of the lucrative scientific advance have trickled down to the communities that gave us vanilla in the first place.
"Wild genetic resources and pharmaceuticals ... are a multi-multi-billion dollar businesses. They clearly are profitable... that's not in dispute," Charles Barber of the World Resources Institute think tank told AFP.
"A great deal of really valuable information has fed into the system from research and utilization of wild genetic resources. And there is no mechanism currently to compensate the people where this information is coming from" in the form of digitally sequenced data, he added.
Much of the information comes from poor countries.
Fair sharing of the gains derived from digitally-stored genetic sequencing data has been a headache for negotiators at the COP16 biodiversity summit into its second week in Cali, Colombia.
At the last conference, in Montreal in 2022, 196 country parties to the UN's Convention on Biological Diversity (CBD) agreed to create a benefit-sharing mechanism for the use of digital sequence information (DSI).
Two years later, they still need to resolve such basic questions as who pays, how much, into which fund, and to whom does the money go?
- 'Cheap and very fast' -
The issue is a complex one.
There is little debate that genetic data-sharing on mostly free-access platforms is crucial for human advancement through medicine and vaccine development, for example.
But how to quantify the value of the sequenced information itself? And should the first people to discover a plant's particular usefulness be compensated?
"Sequencing technology has become so advanced that you can go with a... handheld device a little bit bigger than a cell phone and you can literally sequence a genome in an hour or two and upload it as you sequence it," Pierre du Plessis, a DSI expert and former negotiator for African countries at the CBD told AFP.
These gene sequences are then uploaded to databases which artificial intelligence can mine for potential leads for product development.
DSI is worth an estimated hundreds of billions of dollars a year. And there is a lot of it out there.
"Once the sequence is put into a public database, generally, no benefit-sharing obligations apply," Nithin Ramakrishnan, a researcher with the Third World Network, an advocacy NGO for developing countries, told AFP in Cali.
"Like when the sandalwood sequence information is available in the database whether India wants to share its sandalwood... with a cosmetic company or not, doesn't matter.
- Mandatory -
A point of contention in Cali is a demand from developing countries that payment for DSI use be mandatory, perhaps through a one-percent levy on profits from drugs, cosmetics or other products.
They also want guarantees of non-monetary benefits such as access to vaccines produced from genetic information sequenced from viruses and other pathogens.
"We want real understanding, sector-specific understanding of what non-monetary benefits will be shared and we want the system to be obligatory -- the users should have some form of obligation to share benefits," said Ramakrishnan.
Another sticking point is access for Indigenous people and local communities to DSI funds.
Developing countries want the information on genetic databases to be traceable and "answerable to governments" of the countries where it comes from, said Ramakrishnan.
But rich nations and many researchers oppose such a model which they fear will be too onerous, potentially putting the brakes on scientific pursuits that could benefit all humankind.
With such divergent points of view, observers are doubtful the Cali COP will emerge with any firm decisions on the outstanding questions by closing time on Friday.
The World Wildlife Fund has said "many more rounds of negotiations appear necessary" on DSI.
Added Barber: "I think it's not going to all get solved here."
J.Oliveira--AMWN